Our second conference on Big Data for Pharmacovigilance takes place in September in London. We have an impressive line-up of speakers who will examine the use of Big Data from many perspectives. Highlights include:
- John Rigg, IQVIA: Realising the full potential of artificial intelligence in big populations
- Andrew Bate, Pfizer: Routine and emerging Big Data Strategies for Real World Evidence generation
- Andrew Roddam, GSK: Linking genetic information with clinical data
- Vassilis Koutkias, Centre for Research & Technology Hellas: OpenPVSignal, a tool for electronic exploration of signal reports
- Eva-Lisa Meldau, UMC: De-identification: use of natural language processing to remove patient identifiers from case narratives
- Nigel Hughes, Janssen: Update on EHDEN
- Will Dixon, Manchester University: Recent advances in Digital Epidemiology
- Niklas Noren, UMC: Watch your step – lessons learned in developing and deploying machine learning for pharmacovigilance
- David Martin, FDA: Development of MyStudies App
- Gianmario Candore, EMA: The findings of the HMA-EMA Joint Big Data task force
- and much more!
The conference builds on the huge success of the first conference on Big Data for Pharmacovigilance that we held last year. Read the published summary of this conference here.